283 related articles for article (PubMed ID: 21283131)
1. Association of telomere length with authentic pluripotency of ES/iPS cells.
Huang J; Wang F; Okuka M; Liu N; Ji G; Ye X; Zuo B; Li M; Liang P; Ge WW; Tsibris JC; Keefe DL; Liu L
Cell Res; 2011 May; 21(5):779-92. PubMed ID: 21283131
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.
Wang F; Yin Y; Ye X; Liu K; Zhu H; Wang L; Chiourea M; Okuka M; Ji G; Dan J; Zuo B; Li M; Zhang Q; Liu N; Chen L; Pan X; Gagos S; Keefe DL; Liu L
Cell Res; 2012 Apr; 22(4):757-68. PubMed ID: 22184006
[TBL] [Abstract][Full Text] [Related]
3. Telomere dynamics in human cells reprogrammed to pluripotency.
Suhr ST; Chang EA; Rodriguez RM; Wang K; Ross PJ; Beyhan Z; Murthy S; Cibelli JB
PLoS One; 2009 Dec; 4(12):e8124. PubMed ID: 19956585
[TBL] [Abstract][Full Text] [Related]
4. The role of telomere-binding modulators in pluripotent stem cells.
Li F; Ge Y; Liu D; Songyang Z
Protein Cell; 2020 Jan; 11(1):60-70. PubMed ID: 31350723
[TBL] [Abstract][Full Text] [Related]
5. Telomere regulation in pluripotent stem cells.
Huang Y; Liang P; Liu D; Huang J; Songyang Z
Protein Cell; 2014 Mar; 5(3):194-202. PubMed ID: 24563217
[TBL] [Abstract][Full Text] [Related]
6. Distinct Responses of Stem Cells to Telomere Uncapping-A Potential Strategy to Improve the Safety of Cell Therapy.
Liu CC; Ma DL; Yan TD; Fan X; Poon Z; Poon LF; Goh SA; Rozen SG; Hwang WY; Tergaonkar V; Tan P; Ghosh S; Virshup DM; Goh EL; Li S
Stem Cells; 2016 Oct; 34(10):2471-2484. PubMed ID: 27299710
[TBL] [Abstract][Full Text] [Related]
7. Telomere elongation and naive pluripotent stem cells achieved from telomerase haplo-insufficient cells by somatic cell nuclear transfer.
Sung LY; Chang WF; Zhang Q; Liu CC; Liou JY; Chang CC; Ou-Yang H; Guo R; Fu H; Cheng WTK; Ding ST; Chen CM; Okuka M; Keefe DL; Chen YE; Liu L; Xu J
Cell Rep; 2014 Dec; 9(5):1603-1609. PubMed ID: 25464850
[TBL] [Abstract][Full Text] [Related]
8. Rejuvenation of Cardiac Tissue Developed from Reprogrammed Aged Somatic Cells.
Cheng Z; Peng HL; Zhang R; Fu XM; Zhang GS
Rejuvenation Res; 2017 Oct; 20(5):389-400. PubMed ID: 28478705
[TBL] [Abstract][Full Text] [Related]
9. Different telomere-length dynamics at the inner cell mass versus established embryonic stem (ES) cells.
Varela E; Schneider RP; Ortega S; Blasco MA
Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15207-12. PubMed ID: 21873233
[TBL] [Abstract][Full Text] [Related]
10. Continuous expression of reprogramming factors induces and maintains mouse pluripotency without specific growth factors and signaling inhibitors.
Mao Y; Wang L; Zhong B; Yang N; Li Z; Cui T; Feng G; Li W; Zhang Y; Zhou Q
Cell Prolif; 2021 Aug; 54(8):e13090. PubMed ID: 34197016
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming.
Vaziri H; Chapman KB; Guigova A; Teichroeb J; Lacher MD; Sternberg H; Singec I; Briggs L; Wheeler J; Sampathkumar J; Gonzalez R; Larocca D; Murai J; Snyder E; Andrews WH; Funk WD; West MD
Regen Med; 2010 May; 5(3):345-63. PubMed ID: 20230312
[TBL] [Abstract][Full Text] [Related]
12. Telomere length maintenance, shortening, and lengthening.
Zhao Z; Pan X; Liu L; Liu N
J Cell Physiol; 2014 Oct; 229(10):1323-9. PubMed ID: 24374808
[TBL] [Abstract][Full Text] [Related]
13. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells.
Marion RM; Strati K; Li H; Tejera A; Schoeftner S; Ortega S; Serrano M; Blasco MA
Cell Stem Cell; 2009 Feb; 4(2):141-54. PubMed ID: 19200803
[TBL] [Abstract][Full Text] [Related]
14. Linking Telomere Regulation to Stem Cell Pluripotency.
Liu L
Trends Genet; 2017 Jan; 33(1):16-33. PubMed ID: 27889084
[TBL] [Abstract][Full Text] [Related]
15. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
[TBL] [Abstract][Full Text] [Related]
16. Mechanism and Method for Generating Tumor-Free iPS Cells Using Intronic MicroRNA miR-302 Induction.
Lin SL; Ying SY
Methods Mol Biol; 2018; 1733():265-282. PubMed ID: 29435940
[TBL] [Abstract][Full Text] [Related]
17. Telomere dynamics in human pluripotent stem cells.
Ma B; Martínez P; Sánchez-Vázquez R; Blasco MA
Cell Cycle; 2023; 22(23-24):2505-2521. PubMed ID: 38219218
[TBL] [Abstract][Full Text] [Related]
18. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
Donaires FS; Alves-Paiva RM; Gutierrez-Rodrigues F; da Silva FB; Tellechea MF; Moreira LF; Santana BA; Traina F; Dunbar CE; Winkler T; Calado RT
Stem Cell Res; 2019 Oct; 40():101540. PubMed ID: 31479877
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging.
Kooreman NG; Wu JC
J R Soc Interface; 2010 Dec; 7 Suppl 6(Suppl 6):S753-63. PubMed ID: 20880852
[TBL] [Abstract][Full Text] [Related]
20. Telomere heterogeneity linked to metabolism and pluripotency state revealed by simultaneous analysis of telomere length and RNA-seq in the same human embryonic stem cell.
Wang H; Zhang K; Liu Y; Fu Y; Gao S; Gong P; Wang H; Zhou Z; Zeng M; Wu Z; Sun Y; Chen T; Li S; Liu L
BMC Biol; 2017 Dec; 15(1):114. PubMed ID: 29216888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
